, Tracking Stock Market Picks
Enter Symbol:
Cardiome Pharma Corporation (CRME) [hlAlert]

down 70.13 %

Cardiome Pharma Corporation (CRME) rated Outperform with price target $8.50 by Wedbush

Posted on: Wednesday,  Dec 8, 2010  9:25 AM ET by Wedbush

Wedbush rated Outperform Cardiome Pharma Corporation (NASDAQ: CRME) on 12/08/2010, when the stock price was $29.50. Since
then, Cardiome Pharma Corporation has lost 70.14% as of 08/27/2015's recent price of $8.81.
If you would have followed this Wedbush 's recommendation on CRME, you would have lost 70.13% of your investment in 1723 days.

Cardiome Pharma Corp. is a product-focused cardiovascular drug development company with two clinical drug programs focused on atrial arrhythmia (intravenous and oral dosing), and a pre-clinical program directed at improving cardiovascular function.

Wedbush is Headquartered in Los Angeles, California with over 90 offices and more than 125 correspondent offices, our commitment to providing relentless, customized service is the foundation of our consistent growth. We deliver superior investment ideas and products through exceptional customer care, financial security, continuity and advanced technology.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/8/2010 9:25 AM Buy
29.50 42.50
as of 12/31/2010
1 Week up  12.54 %
1 Month up  11.01 %
3 Months   
1 YTD up  11.01 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy